Lv1
40 积分 2021-08-16 加入
4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy
11小时前
待确认
Chapter Three - Evaluating outcomes within culturally diverse contexts for children and youth with developmental disabilities
5个月前
已完结
Developmental Milestones in the Newborn Mouse
5个月前
已完结
Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients
5个月前
已完结
A small-molecule activation mechanism that directly opens the KCNQ2 channel
8个月前
已完结
Neurodevelopmental Outcomes Prediction in Newborns with Seizures Caused by <i>KCNQ2</i> Gene Defects
8个月前
已完结
The aminosteroid U73122 promotes oligodendrocytes generation and myelin formation
1年前
已完结
Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy
1年前
已完结
KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons
1年前
已完结
Understanding the pathogenetic mechanisms underlying altered neuronal function associated with CAMK2B mutations
1年前
已完结
皖公网安备34019202002308
